3 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
| Phase 2 | 1 | Terminated 1 |
Follow Keratosis: new trials by email Literature Review of Keratosis trials Research Report on Keratosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma ADI PEG20, Ifosfamide, Radiotherapy - Soft Tissue Sarcoma, Sts | Phase 1 | Terminated | Washington University School of Medicine | 6 | 2024-03-14 | 2026-09-03 |
| A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome DS-2325a, Placebo - Netherton Syndrome | Phase 1 / Phase 2 | Terminated | Daiichi Sankyo | 9 | 2023-09-28 | 2026-05-14 |
| Photodynamic Therapy-Induced Immune Modulation: Part III Celecoxib 200mg, Placebo - Actinic Keratosis, Photodynamic Therapy | Phase 1 | Terminated | Wright State University | 12 | 2019-04-01 | 2024-12-19 |
Ichthyosis, X-Linked (1) · Keratosis, Actinic (1) · Netherton Syndrome (1) · Sarcoma (1)
Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Ichthyosis (2) · Infant, Newborn, Diseases (2) · Neoplasms (2) · Skin Abnormalities (2) · Skin Diseases, Genetic (2) · Abnormalities, Multiple (1) · Genetic Diseases, X-Linked (1) · Ichthyosiform Erythroderma, Congenital (1) · Metabolic Diseases (1)
ADI PEG20 (1) · Celecoxib (1) · Ifosfamide (1) · Mesna (1) · Radiotherapy (1)
Daiichi Sankyo (1) · Washington University School of Medicine (1) · Wright State University (1)
United States (2) · France (1)
Jeffrey B Travers, MD, PhD (1) · Mia Weiss, M.D. (1)